Ferroptosis Inhibitors as Potential New Therapeutic Targets for Cardiovascular Disease

Area of Science:

• Cardiovascular Biology
• Cell Death Mechanisms
• Biochemistry

Background:

• Ferroptosis is an iron-dependent form of programmed cell death.
• It plays a significant role in cardiovascular diseases such as myocardial infarction, reperfusion injury, and heart failure.
• Understanding ferroptosis is crucial as cardiomyocyte loss drives morbidity and mortality in these conditions.

Purpose of the Study:

• To review the role of ferroptosis in cardiovascular diseases.
• To update knowledge on the molecular mechanisms regulating ferroptosis.
• To discuss the therapeutic potential of ferroptosis inhibitors in cardiovascular medicine.

Main Methods:

• Literature review focusing on ferroptosis and cardiovascular pathology.
• Analysis of molecular pathways governing iron, lipid, amino acid, and glutathione metabolism in ferroptosis.
• Examination of existing and potential ferroptosis inhibitors.

Main Results:

• Ferroptosis is intricately regulated by iron, lipid, amino acid, and glutathione metabolism.
• Inhibitors like iron chelators, antioxidants, GPX4 activators, and LPO inhibitors can mitigate ferroptosis.
• Identifying novel molecular targets for ferroptosis inhibition is critical for cardiovascular disease research.

Conclusions:

• Ferroptosis is a key player in cardiovascular disease pathogenesis.
• Targeting ferroptosis pathways presents a viable therapeutic avenue for cardiovascular disorders.
• Further research into novel molecular targets is essential for developing effective treatments.